2432-2433 / 2953
EORTC-22961: Increased overall survival and reduced prostate
cancer mortality with long-term adjuvant HT
Bolla M, et al. NEJM 2009;360:2516–27
HT, hormone therapy; STAS: short-term androgen suppression LTAS: long-
term androgen suppression